Sr. Director, Clinical Pharmacology & Pharmacometrics

GondolaBio, LLC; Palo Alto (CA); Hybrid; USD 250,000 - 380,000; Full time

Job summary

GondolaBio is seeking a Sr. Director of Clinical Pharmacology & Pharmacometrics to lead early clinical pharmacology and quantitative pharmacology, inform dose selection, and guide development decisions for oligonucleotide therapies in a fast-moving biotech.

You will set strategy at the portfolio level while contributing hands-on across programs, reporting to the Chief Development Officer, and collaborating with cross-functional teams from remote U.S. to on-site Palo Alto.

Job description

All Jobs > Sr. Director, Clinical Pharmacology & Pharmacometrics

Sr. Director, Clinical Pharmacology & Pharmacometrics

Fully Remote CA

Full-time

Description

Sr. Director, Clinical Pharmacology & Pharmacometrics

Reports to: Chief Development Officer

Location: Remote U.S. or On-site/Hybrid Palo Alto

About GondolaBio

GondolaBio is a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics for genetic diseases. GondolaBio is an independent sister company to BridgeBio, originally carved out in 2024 after securing $300M in private financing from external investors. GondolaBio aims to leverage cutting-edge biological research to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases.

The Role

You are an experienced clinical pharmacology and quantitative pharmacology leader with deep expertise in early clinical development and a strong track record of informing dose selection and development decisions for oligonucleotide therapies. You are comfortable setting strategy at the portfolio and program level while also rolling up your sleeves to execute in a small, fast-moving biotech environment, and you are energized by the opportunity to help build and shape clinical pharmacology and pharmacom